Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory loss? That’s the potential promise of a new class of biomark ...

At the 20th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) in Copenhagen, Eli Lilly and Company presented new data evaluating the ...

Neuropsychological assessment, or cognitive testing, is the gold standard tool for measuring cognitive functions (or the “software” of the brain) such as memory, language, attention, visuospatial ...

COLUMBUS, Ohio (WCMH) — A 2024 study has found a tool developed by researchers at the Ohio State University Wexner Medical Center (OSUWMC) is effective in early diagnosis of cognitive disorders when ...

Routine early measurement of neurofilament light chain could help improve prediction of cognitive impairment after ...

In real-world clinical practice, adding p‑tau217 testing significantly improved diagnostic accuracy and increased neurologists' diagnostic confidence, with marked reclassification seen in mild ...

Add Yahoo as a preferred source to see more of our stories on Google. President Biden at the debate on June 27. (Kyle Mazza/Anadolu via Getty Images) (Anadolu via Getty Images) At 81, President Biden ...

Researchers have found in a new study that pupil dilation could serve as an indicator of attention and mental effort in ...

Pooled analyses in patients with moderate Alzheimer’s show dose-related cognitive benefit and signs of durability. 100% of patients remained stable or improved, with 50% improving from moderate to ...

Medication-related cognitive impairment is common, mimics neurodegenerative disease, increases with polypharmacy, and may be prevented with regular cognitive assessment monitoring.